As you plan your 84th Scientific Sessions itinerary, here are some program highlights to consider from more than 200 sessions planned for the meeting, taking place June 21-24 in Orlando.
“As always, the entire Scientific Sessions is going to feature the best in the world at the top of their game from a scientific perspective sharing their expertise. There are so many different speakers and abstract presenters,” said Scientific Sessions Meeting Planning Committee Chair Alice Y.Y. Cheng, MD, FRCPC. “We’ll have the established experts, but also a diversity of speakers that will include the younger generations and up-and-coming stars. So, we get to see the present and the future of diabetes.”
- Friday, 3:45 p.m.: SURMOUNT-OSA Trial Results and Potential Role of Tirzepatide in Treating Obesity-Related Obstructive Sleep Apnea (includes livestream)
- Saturday, 8 a.m.: The Efficacy and Safety of Inhaled Insulin Used with Insulin Degludec Compared with Automated Insulin Delivery or Multiple Daily Insulin Injections in Adults with Type 1 Diabetes—Results of the INHALE-3 Randomized Trial (includes livestream)
- Saturday, 8 a.m.: SELECT Trial—New Looks at Glycemia, Inflammation, and Heart Failure (includes livestream)
- Saturday, 8 a.m.: Navigating the Early Phases of Pediatric Type 1 Diabetes
- Saturday, 3:15 p.m.: Optimizing Outcomes of GLP-1+/GIP Receptor Agonists—How to Help Patients Succeed
- Saturday, 3:15 p.m.: Intermittent Fasting in Various Forms of Diabetes Care
- Sunday, 8 a.m.: Diabetes and Organ Transplantation—Pathophysiology, Inpatient and Outpatient Management
- Sunday, 4:30 p.m.: Keeping Up with Hollywood—Who Should Be Prioritized for New Antiobesity Medications?
- Sunday, 4:30 p.m.: THE STEP-HFpEF and STEP-HFpEF-DM Trials—Targeting Obesity to Treat Heart Failure (Includes Livestream)
- Monday, 8 a.m.: Myth Busters on “Category X” Drugs in Pregnancy—Evidence for Stopping Commonly Used Medications During Pregnancy, Preconception, and Lactation
- Monday, 8 a.m.: ADA Symposium—Major Advances and Discoveries in Diabetes—The Year in Review (includes livestream)
- Monday, 8 a.m.: Cost and Quality—Improving Diabetes Care and the Cost of Ongoing Inequities
- Monday, 1:30 p.m.: The First Dedicated Kidney Outcome Trial with a GLP-1 Receptor Agonist Once-Weekly Semaglutide and the FLOW Trial Results (includes livestream)
- Monday, 3:15 p.m.: Use of SGLT2i in Youth with Type 1 Diabetes—Results from ATTEMPT (The Adolescent Type 1 Diabetes Treatment with SGLT2i for hyperglycEMia & hyPerfilTration Trial) (includes livestream)
- Monday, 3:15 p.m.: Results from a Randomized Trial of Intensive Glucose Management Using Continuous Glucose Monitoring (CGM) Versus Usual Care in Hospitalized Adults with Type 2 Diabetes—The TIGHT Study (includes livestream)
- Monday, 3:15 p.m.: Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes – the CATALYST Trial
- Monday, 3:15 p.m.: Leptin, 30 years Later (panel discussion)
For more details on session offerings, visit the Online Planner.
Full, in-person meeting registration includes access to on-demand recordings of sessions through Aug. 26.
Register Today for the 84th Scientific Sessions
Join us in Orlando for the 84th Scientific Sessions, June 21-24. Full in-person registration includes access to all of the valuable onsite content during the meeting and on-demand access to the virtual program June 25-Aug. 26. For those unable to join us in-person, we are planning a virtual program to allow as many people as possible to participate and learn about the latest advances in diabetes research, prevention, and care.